Subscribe free

Cytoreductive Surgery & Peritoneum ·

Identification of Key Risk Factors for Postoperative Kidney Injury

A meta-analysis of seven studies involving 1,550 patients has pinpointed significant preoperative and intraoperative risk factors for acute kidney injury (AKI) after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC). Preoperative factors include age, sex, BMI, and diabetes, while intraoperative factors include low systolic blood pressure and cisplatin use; however, mitomycin shows protective effects. Variations in AKI risk corresponded to primary tumor sites, highlighting the need for tailored preoperative interventions.

Review by Chen D, Ma Y (…) Yao X et 6 al. in World J Surg Oncol

© 2025. The Author(s).

read the whole article in World J Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Cytoreductive Surgery & Peritoneum.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Cytoreductive Surgery & Peritoneum

The latest stitches

Ann Surg Oncol28 Aug 2026

Prophylactic HIPEC Improves Survival in Advanced Colorectal Cancer

Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) significantly enhances peritoneal metastasis-free survival and disease-free survival in patients with locally advanced colorectal cancer, though overall survival rates and complication rates remain unchanged.

All papers in Cytoreductive Surgery & Peritoneum →